Inhibition of KLF6 reduces the inflammation and apoptosis of type II alveolar epithelial cells in acute lung injury
Main Article Content
Keywords
acute lung injury, apoptosis, inflammation, KLF6, type II alveolar epithelial cells
Abstract
Background: The development of acute lung injury (ALI) into a severe stage leads to acute respiratory distress syndrome (ARDS). The morbidity and mortality of ALI and ARDS are very high. Objective: This study is aimed to explore the effect of Krüppel-like factor 6 (KLF6) on lipopolysaccharide (LPS)-induced type II alveolar epithelial cells in ALI by interacting with cysteine-rich angiogenic inducer 61 (CYR61).
Material and Methods: ALI mice model and LPS-induced type II alveolar epithelial cells were conducted to simulate ALI in vivo and in vitro. The messenger RNA (mRNA) and protein expression of KLF6 in lung tissues were detected by reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and Western blot analysis. Pathological changes in lung tissues were observed by hematoxylin and eosin (H&E) staining. The viability and KLF6 expression of A549 cells treated with different concentrations of LPS were detected by cell counting kit-8 (CCK-8) assay, RT-qPCR, and Western blot analysis. After indicated treatment, the viability and apoptosis of A549 cells were analyzed by CCK-8 and TUNEL assays, and the inflammation factors of A549 cells were detected by Enzyme-linked-immunosorbent serologic assay, RT-qPCR, and Western blot analysis. The combination of KLF6 and CYR61 was determined by chromatin immunoprecipitation (ChIP)-PCR and dual-luciferase reporter assay.
Results: KLF6 expression was increased in lung tissues of ALI mice and LPS-induced A549 cells. Interference with KLF6 improved the viability, reduced the inflammatory damage, and promoted the apoptosis of LPS-induced A549 cells. In addition, KLF6 could bind to CYR61. Interference with KLF6 could decrease CYR61 expression in LPS-induced A549 cells. LPS also enhanced the TLR4/MYD88 signaling pathway, which was reversed by KLF6 interference. The above phenomena in LPS-induced A549 cells transfected with Si-KLF6 could be reversed by overexpression of CYR61.
Conclusion: Inhibition of KLF6 promoted the viability and reduced the inflammation and apoptosis of LPS-induced A549 cells, which was reversed by CYR61.
References
2. Mokra D, Kosutova P. Biomarkers in acute lung injury. Resp Physiol Neurobiol. 2015;209:52–8. 10.1016/j.resp.2014.10.006
3. Dupuis J, Sirois MG, Rhéaume E, Nguyen QT, Clavet-Lanthier M, Brand G, et al. Colchicine reduces lung injury in experimental acute respiratory distress syndrome. PloS One. 2020;15:e0242318. 10.1371/journal.pone.0242318
4. Butt Y, Kurdowska A, Allen TC. Acute lung Injury: A clinical and molecular review. Arch Pathol Lab Med. 2016;140:345–50. 10.5858/arpa.2015-0519-RA
5. Zhang Y, Lei CQ, Hu YH, Xia T, Li M, Zhong B, et al. Krüppel-like factor 6 is a co-activator of NF-κB that mediates p65-dependent transcription of selected downstream genes. J Biol Chem. 2014;289:12876–85. 10.1074/jbc.M113.535831
6. Date D, Das R, Narla G, Simon DI, Jain MK, Mahabeleshwar GH. Kruppel-like transcription factor 6 regulates inflammatory macrophage polarization. J Biol Chem. 2014;289:10318–29. 10.1074/jbc.M113.526749
7. Zhao H, Chen B, Li Z, Wang B, Li L. Long noncoding RNA DANCR suppressed lipopolysaccharide-induced septic acute kidney injury by regulating miR-214 in HK-2 cells. Med Sci Monit Int Med J Exper Clin Res. 2020;26:e921822. 10.12659/MSM.921822
8. Li W, Wang J, Hao W, Yu C. MicroRNA-543-3p down-regulates inflammation and inhibits periodontitis through KLF6. Biosci Rep. 2021;41:BSR20210138. 10.1042/BSR20210138
9. Sydor S, Manka P, Best J, Jafoui S, Sowa JP, Zoubek ME, et al. Krüppel-like factor 6 is a transcriptional activator of autophagy in acute liver injury. Sci Rep. 2017;7:8119. 10.1038/s41598-017-08680-w
10. Mgbemena V, Segovia J, Chang TH, Bose S. KLF6 and iNOS regulates apoptosis during respiratory syncytial virus infection. Cell Immunol. 2013;283:1–7. 10.1016/j.cellimm.2013.06.002
11. Zou XZ, Gong ZC, Liu T, He F, Zhu TT, Li D, et al. Involvement of epithelial-mesenchymal transition afforded by activation of LOX-1/TGF-β1/KLF6 signaling pathway in diabetic pulmonary fibrosis. Pulmon Pharmacol Ther. 2017;44:70–7. 10.1016/j.pupt.2017.03.012
12. Ribeiro A, Ferraz-de-Paula V, Pinheiro ML, Vitoretti LB, Mariano-Souza DP, Quinteiro-Filho WM, et al. Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: Role for the adenosine A(2A) receptor. Eur J Pharmacol. 2012;678:78–85. 10.1016/j.ejphar.2011.12.043
13. Costola-de-Souza C, Ribeiro A, Ferraz-de-Paula V, Calefi AS, Aloia TP, Gimenes-Júnior JA, et al. Monoacylglycerol lipase (MAGL) inhibition attenuates acute lung injury in mice. PloS One. 2013;8:e77706. 10.1371/journal.pone.0077706
14. Ribeiro A, Almeida VI, Costola-de-Souza C, Ferraz-de-Paula V, Pinheiro ML, Vitoretti LB, et al. Cannabidiol improves lung function and inflammation in mice submitted to LPS-induced acute lung injury. Immunopharmacol Immunotoxicol. 2015;37:35–41. 10.3109/08923973.2014.976794
15. Barreto TR, Costola-de-Souza C, Margatho RO, QueirozHazarbassanov N, Rodrigues SC, Felício LF, et al. Repeated domperidone treatment modulates pulmonary cytokines in LPS-induced acute lung injury in mice. Int Immunopharmacol. 2018;56:43–50. 10.1016/j.intimp.2018.01.009
16. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods (San Diego CA). 2001;25:402–8. 10.1006/meth.2001.1262
17. Xiang B, Chen L, Wang X, Zhao Y, Wang Y, Xiang C. Transplantation of menstrual blood-derived mesenchymal stem cells promotes the repair of LPS-induced acute lung injury. Int J Mol Sci. 2017;18:689. 10.3390/ijms18040689
18. Zhao J, Yu H, Liu Y, Gibson SA, Yan Z, Xu X, et al. Protective effect of suppressing STAT3 activity in LPS-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2016;311:L868–80. 10.1152/ajplung.00281.2016
19. Schneider J, Sweberg T. Acute respiratory failure. Crit Care Clin. 2013;29:167–83. 10.1016/j.ccc.2012.12.004
20. von Dossow-Hanfstingl V. Advances in therapy for acute lung injury. Anesthesiol Clin. 2012;30:629–39. 10.1016/j.anclin.2012.08.008
21. Shafeeq H, Lat I. Pharmacotherapy for acute respiratory distress syndrome. Pharmacotherapy. 2012;32:943–57. 10.1002/j.1875-9114.2012.01115
22. Matthay MA, Goolaerts A, Howard JP, Lee JW. Mesenchymal stem cells for acute lung injury: Preclinical evidence. Crit Care Med. 2010;38:S569–73. 10.1097/CCM.0b013e3181f1ff1d
23. Bellingan G, Maksimow M, Howell DC, Stotz M, Beale R, Beatty M, et al. The effect of intravenous interferon-beta-1a (FP-1201) on lung CD73 expression and on acute respiratory distress syndrome mortality: An open-label study. Lancet Resp Med. 2014;2:98–107. 10.1016/S2213-2600(13)70259-5
24. Vettorazzi S, Bode C, Dejager L, Frappart L, Shelest E, Klaßen C, et al. Glucocorticoids limit acute lung inflammation in concert with inflammatory stimuli by induction of SphK1. Nat Commun. 2015;6:7796. 10.1038/ncomms8796
25. Kim GD, Das R, Goduni L, McClellan S, Hazlett LD, Mahabeleshwar GH. Kruppel-like factor 6 promotes macrophage-mediated inflammation by suppressing B cell leukemia/lymphoma 6 expression. J Biol Chem. 2016;291:21271–82. 10.1074/jbc.M116.738617
26. Kim GD, Ng HP, Patel N, Mahabeleshwar GH. Kruppel-like factor 6 and miR-223 signaling axis regulates macrophage-mediated inflammation. FASEB J. 2019;33:10902–15. 10.1096/fj.201900867RR
27. Li D, Liu X, Li C, Zhang Y, Guan C, Huang J, et al. Role of promoting inflammation of Krüppel-like factor 6 in acute kidney injury. Renal Fail. 2020;42:693–703. 10.1080/0886022X.2020.1793353
28. Morrell ED, Grazioli S, Hung C, Kajikawa O, Kosamo S, Stapleton RD, et al. Alveolar CCN1 is associated with mechanical stretch and acute respiratory distress syndrome severity. Am J Physiol Lung Cell Mol Physiol. 2020;319:L825–32. 10.1152/ajplung.00073.2020
29. Grazioli S, Gil S, An D, Kajikawa O, Farnand AW, Hanson JF, et al. CYR61 (CCN1) overexpression induces lung injury in mice. Am J Physiol Lung Cell Mol Physiol. 2015;308:L759–65. 10.1152/ajplung.00190.2014
30. Shi L, Dong N, Ji D, Huang X, Ying Z, Wang X, et al. Lipopolysaccharide-induced CCN1 production enhances interleukin-6 secretion in bronchial epithelial cells. Cell Biol Toxicol. 2018;34:39–49. 10.1007/s10565-017-9401-1
31. Jun JI, Lau LF. CCN1 is an opsonin for bacterial clearance and a direct activator of toll-like receptor signaling. Nature Comm. 2020;11:1242. 10.1038/s41467-020-15075-5
32. Tang J, Xu L, Zeng Y, Gong F. Effect of gut microbiota on LPS-induced acute lung injury by regulating the TLR4/NF-kB signaling pathway. Int Immunopharmacol. 2021;91:107272. 10.1016/j.intimp.2020.107272
33. Li XX, Yuan R, Wang QQ, Han S, Liu Z, Xu Q, et al. Rotundic acid reduces LPS-induced acute lung injury in vitro and in vivo through regulating TLR4 dimer. Phytother Res (PTR). 2021;35:4485–98. 10.1002/ptr.7152
34. Wu X, Lin L, Wu H. Ferulic acid alleviates lipopolysaccharide-induced acute lung injury through inhibiting TLR4/NF-κB signaling pathway. J Biochem Mol Toxicol. 2021;35:e22664. 10.1002/jbt.22664
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.